AKEEGA cpr pell 50mg/500mg 56 pce
7680689770017
Pharmacode 1050908
CH-68977
L01XK52
07.16.4.
Active substances:
1 / 3
google
Details
- GTIN
- 7680689770017
- Pharmacode
- 1050908
- Product number
- 6897701
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- niraparibum 50 mg ut niraparibi tosilas monohydricus 79.7 mg, abirateroni acetas 500 mg corresp. abirateronum 446 mg, hypromellosum, natrii laurilsulfas, lactosum 240.54 mg ut lactosum monohydricum, crospovidonum, cellulosum microcristallinum silicificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, glyceroli monocaprylocapras, talcum, natrii laurilsulfas, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 5.05 mg.
Articles (1)
Akeega 50 mg/500 mg, Filmtabletten
Filmtabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
niraparibum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
niraparibi tosilas monohydricus
|
79.7 MG | Substance | WIZUS |
|
abirateroni acetas
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
abirateronum
|
446.0 MG | Substance | WIIS |
|
hypromellosum
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
lactosum
|
240.54 MG | Substance | HBESI |
|
lactosum monohydricum
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum silicificatum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
glyceroli monocaprylocapras
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
natrium
|
5.05 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 4523.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2024
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 68977
- Drug name
- Akeega, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01XK52
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/04/2024
- Authorization expiration date
- 17/04/2029
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AKEEGA cpr pell 50mg/500mg 56 pce
- Description (DE)
- AKEEGA Filmtabl 50mg/500mg 56 Stk
- Market launch
- 27/05/2024
- Narcotic (BTM)
- No